Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-13 Purchase | 2022-05-13 7:05 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 2,500 | $82.76 | $206,910 | 173,354 (Direct) | View |
| 2022-02-28 Sale | 2022-03-01 4:34 pm | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 908 | $102.62 | $93,179 | 41,209 (Direct) | View |
| 2021-11-16 Sale | 2021-11-17 5:06 pm | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 4,835 | $161.86 | $782,579 | 25,398 (Direct) | View |
| 2021-11-12 Sale | 2021-11-12 7:31 pm | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 3,000 | $160.5 | $481,500 | 335,095 (Direct) | View |
| 2021-11-11 Sale | 2021-11-12 4:54 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 11,160 | $163.02 | $1,819,255 | 190,873 (Direct) | View |
| 2021-08-04 Sale | 2021-08-05 4:44 pm | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 8,840 | $109.67 | $969,507 | 202,595 (Direct) | View |
| 2021-02-10 Sale | 2021-02-12 6:23 pm | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 5,083 | $213.14 | $1,083,410 | 50,152 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-09 Exercise | 2022-05-10 5:33 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 8,000 | $21.92 | 1,131,209 (Direct) | View |
| 2022-05-09 Exercise | 2022-05-10 5:33 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 8,000 | $0 | 1,131,209 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 8:10 pm | N/A 2032-05-05 | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 20,126 | $0 | 20,126 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 8:10 pm | N/A 2032-05-05 | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 30,189 | $0 | 30,189 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 8:10 pm | N/A 2032-05-05 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 34,214 | $0 | 34,214 (Direct) | View |
| 2022-05-05 Option Award | 2022-05-09 8:09 pm | N/A 2032-05-05 | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 76,478 | $0 | 76,478 (Direct) | View |
| 2022-02-28 Exercise | 2022-03-01 4:34 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 7,335 | $12.53 | 41,209 (Direct) | View |
| 2022-02-28 Exercise | 2022-03-01 4:34 pm | N/A 2022-05-31 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 7,335 | $0 | 41,209 (Direct) | View |
| 2022-02-15 Tax Withholding | 2022-02-16 8:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 1,578 | $123.68 | 30,394 (Direct) | View |
| 2022-02-15 Tax Withholding | 2022-02-16 8:24 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 3,546 | $123.68 | 170,854 (Direct) | View |
| 2022-02-15 Tax Withholding | 2022-02-16 8:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 5,923 | $123.68 | 340,593 (Direct) | View |
| 2022-02-15 Tax Withholding | 2022-02-16 8:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 3,407 | $123.68 | 44,306 (Direct) | View |
| 2021-12-31 Ownership | 2022-02-07 7:29 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 2,502 | $0 | 332,593 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 8:43 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 11,651 | $0 | 47,713 (Direct) | View |
| 2022-01-26 Tax Withholding | 2022-01-28 8:43 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 3,628 | $113.68 | 47,713 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 8:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 23,166 | $0 | 349,018 (Direct) | View |
| 2022-01-26 Tax Withholding | 2022-01-28 8:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 9,243 | $113.68 | 349,018 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 8:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 6,237 | $0 | 31,972 (Direct) | View |
| 2022-01-26 Tax Withholding | 2022-01-28 8:42 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 2,156 | $113.68 | 31,972 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 8:41 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 13,000 | $0 | 174,400 (Direct) | View |
| 2022-01-26 Tax Withholding | 2022-01-28 8:41 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 5,125 | $113.68 | 174,400 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-17 5:06 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 4,835 | $32.3 | 25,398 (Direct) | View |
| 2021-11-16 Exercise | 2021-11-17 5:06 pm | N/A 2023-06-11 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 4,835 | $0 | 25,398 (Direct) | View |
| 2021-11-11 Exercise | 2021-11-12 4:54 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 11,160 | $21.92 | 190,873 (Direct) | View |
| 2021-11-11 Exercise | 2021-11-12 4:54 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,028 | $100.38 | 190,873 (Direct) | View |
| 2021-11-11 Exercise | 2021-11-12 4:54 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 12,188 | $0 | 190,873 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-05 4:44 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 8,840 | $21.92 | 202,595 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-05 4:44 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,142 | $85.79 | 202,595 (Direct) | View |
| 2021-08-04 Exercise | 2021-08-05 4:44 pm | N/A 2023-02-15 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 9,982 | $0 | 202,595 (Direct) | View |
| 2021-07-12 Option Award | 2021-07-14 8:19 pm | 2022-07-12 2031-07-12 | LIGAND PHARMACEUTICALS INC | LGND | Cochran Jennifer R. Director | 5,669 | $0 | 5,669 (Direct) | View |
| 2021-06-30 Other | 2021-07-02 5:14 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 247 | $85.91 | 338,342 (Direct) | View |
| 2021-06-30 Other | 2021-07-02 5:13 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 247 | $85.91 | 39,937 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 2:26 pm | N/A 2031-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Sabba Stephen L Director | 3,899 | $0 | 30,798 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 9:39 pm | N/A 2031-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Aryeh Jason Director | 3,899 | $0 | 128,552 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 9:25 pm | N/A 2031-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Boyce Sarah Director | 3,899 | $0 | 6,161 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 9:25 pm | N/A 2031-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 3,899 | $0 | 54,051 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 9:24 pm | N/A 2031-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Gray Nancy Ryan Director | 3,899 | $0 | 6,971 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 9:24 pm | N/A 2031-06-04 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 3,899 | $0 | 38,051 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 9:24 pm | N/A 2031-06-04 | LIGAND PHARMACEUTICALS INC | LGND | LAMATTINA JOHN L Director | 3,899 | $0 | 28,667 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-07 9:23 pm | N/A 2031-06-04 | LIGAND PHARMACEUTICALS INC | LGND | Patel Sunil Director | 3,899 | $0 | 32,089 (Direct) | View |
| 2021-05-28 Exercise | 2021-06-01 4:59 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,755 | $56.26 | 204,713 (Direct) | View |
| 2021-05-28 Exercise | 2021-06-01 4:59 pm | N/A 2025-02-10 | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 1,755 | $0 | 204,713 (Direct) | View |
| 2021-05-28 Gift | 2021-06-01 4:59 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 2,500 | $0 | 204,713 (Direct) | View |
| 2021-05-11 Tax Withholding | 2021-05-13 8:57 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 391 | $128.56 | 34,152 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:57 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 4,835 | $10.12 | 34,152 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:57 pm | N/A 2012-06-01 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 4,835 | $0 | 34,152 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-23 5:18 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,500 | $10.12 | 34,543 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-23 5:18 pm | N/A 2012-06-01 | LIGAND PHARMACEUTICALS INC | LGND | KOZARICH JOHN W Director | 2,500 | $0 | 34,543 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Berkman Charles S VP | 1,015 | $172.46 | 27,891 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:28 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | FOEHR MATTHEW W COO | 3,098 | $172.46 | 165,100 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | HIGGINS JOHN L CEO | 5,212 | $172.46 | 337,848 (Direct) | View |
| 2021-02-15 Tax Withholding | 2021-02-18 6:27 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Korenberg Matthew E CFO | 2,309 | $172.46 | 39,443 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-12 6:23 pm | N/A N/A | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,474 | $195.91 | 50,152 (Direct) | View |
| 2021-02-10 Exercise | 2021-02-12 6:23 pm | N/A 2028-06-18 | LIGAND PHARMACEUTICALS INC | LGND | Davis Todd C Director | 2,474 | $0 | 50,152 (Direct) | View |